Japan’s 2012 New Drug Approval Period Shortest Since 2000
This article was originally published in PharmAsia News
Executive Summary
The approval time for new drugs in Japan was a median of 9.5 months in 2012, 0.6 months shorter than the previous year and shorter than any year since 2000, according to research carried by the JPMA Office of Pharmaceutical Research.